Sanuwave health inc stock is down -100% since 30 days ago. The next earnings date is Apr 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 46.67% of the previous 14 December’s closed higher than November.
SANUWAVE Health, Inc. researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses.